NASDAQ: PCRX
Pacira Biosciences Inc Stock Ownership - Who owns Pacira Biosciences?

Insider buying vs selling

Have Pacira Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan SloninChief Medical Officer2025-01-06879$18.40
$16.17kSell
Lauren RikerSenior Vice President Finance2025-01-02159$18.33
$2.91kSell
Frank D. LeeChief Executive Officer2025-01-029,375$18.33
$171.84kSell
Jonathan SloninChief Medical Officer2025-01-02371$18.33
$6.80kSell
Daryl GauglerChief Operating Officer2024-12-31243$16.01
$3.89kBuy
Daryl GauglerChief Operating Officer2024-12-13500$19.76
$9.88kSell
Daryl GauglerChief Operating Officer2024-09-13500$12.86
$6.43kSell
Marcelo BigalDirector2024-08-161,512$13.25
$20.03kBuy
Laura BregeDirector2024-08-161,000$12.81
$12.81kBuy
Michael J. YangDirector2024-08-142,000$12.90
$25.80kBuy

1 of 3

PCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCRX insiders and whales buy or sell their stock.

PCRX Shareholders

What type of owners hold Pacira Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.66%7,709,819$199.68MInstitution
Orbimed Advisors LLC11.40%5,274,941$136.62MInsider
Vanguard Group Inc11.37%5,263,919$136.34MInstitution
Andreas Wicki8.83%4,085,359$105.81MInsider
Pacer Advisors Inc7.05%3,262,837$84.51MInstitution
Carl L. Gordon6.11%2,828,941$73.27MInsider
Mpm Bioventures IV Qp LP6.03%2,790,479$72.27MInsider
Vaughn M. Kailian6.03%2,790,479$72.27MInsider
D E Shaw Co Inc4.88%2,257,474$58.47MInstitution
Hbm Healthcare Investments Cayman Ltd4.83%2,233,993$57.86MInsider

1 of 3

PCRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCRX68.43%31.57%Net Selling
AMPH50.42%49.58%Net BuyingNet Buying
INDV62.35%0.00%
DVAX65.89%34.11%Net SellingNet Selling
EVO5.00%0.00%

Pacira Biosciences Stock Ownership FAQ

Who owns Pacira Biosciences?

Pacira Biosciences (NASDAQ: PCRX) is owned by 107.97% institutional shareholders, 49.82% Pacira Biosciences insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Pacira Biosciences shareholder, owning 5.27M shares representing 11.40% of the company. Orbimed Advisors LLC's Pacira Biosciences shares are currently valued at $134.25M.

If you're new to stock investing, here's how to buy Pacira Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.